市場調查報告書
商品編碼
1494672
疝氣修補市場:按產品類型、手術、適應症和最終用戶分類 - 全球預測 2024-2030Hernia Repair Market by Product Type (Hernia Mesh, Mesh Fixator, Suture), Surgery (Laparoscopic Surgery, Open Surgery, Robotic Surgery), Indication, End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年疝氣修補市場規模為45.6億美元,預計2024年將達47.8億美元,2030年將達65.2億美元,複合年成長率為5.23%。
疝氣修補是指一種旨在糾正器官從周圍肌肉或組織壁撕裂處突出時發生的疝氣的外科手術。當器官透過周圍肌肉或組織壁的撕裂突出時,就會發生疝氣。這種情況通常可以透過開放性手術或微創手術來矯正。促進疝氣修復手術擴大的關鍵因素包括對該疾病的認知增加、手術技術的進步以及肥胖症(疝氣的主要危險因子)盛行率的增加。然而,疝氣修補手術並非沒有風險,例如感染、復發,以及某些情況下的慢性術後疼痛。解決這些問題需要繼續研究更先進的手術技術、材料和術後護理通訊協定,以減輕這些風險並促進患者康復。網片材料和技術的創新,例如生物可吸收網片和機器人輔助手術的開發,有望改善手術結果並減少併發症,從而促進疝氣修復手術在全球的普及。
主要市場統計 | |
---|---|
基準年[2023] | 45.6億美元 |
預測年份 [2024] | 47.8億美元 |
預測年份 [2030] | 65.2億美元 |
複合年成長率(%) | 5.23% |
區域洞察
在美國,特別是美國,由於強大的醫療基礎設施和大量的研發投資,對技術先進的疝氣修復產品(例如複合網片和生物同種異體移植物)的需求很高。該地區的主要企業受益於強大的分銷網路和全面的產品系列。由於人們對先進疝氣修復方案的認知不斷提高、醫療成本不斷增加以及醫療保健設施不斷改善,亞太地區的疝氣修復術正在迅速成長。然而,該地區的市場更加分散,全球和本地參與者都存在,導致產品範圍多樣化和具有競爭力的定價策略。 EMEA(歐洲、中東和非洲)地區面臨著多種場景,西歐已開發市場注重創新和質量,而中東和非洲市場對價格敏感並逐漸採用新技術。區域公司正在擴大在歐洲、中東和非洲地區的業務,提供先進且經濟高效的解決方案組合,以滿足多樣化的市場需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在疝氣修補市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對疝氣修復市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在疝氣修復市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Hernia Repair Market size was estimated at USD 4.56 billion in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 5.23% to reach USD 6.52 billion by 2030.
Hernia repair refers to a surgical procedure aimed at correcting hernias, which occur when an organ protrudes through a tear in the surrounding muscle or tissue wall. This condition is often corrected through either open surgery or minimally invasive surgeries. The major factors contributing to the expansion of hernia repair procedures include the increasing awareness of the condition, advancements in surgical technologies, and the rising prevalence of obesity, which is a major risk factor for hernias. However, hernia repair procedures are not without their risks, including the risk of infection, recurrence, and, in some cases, chronic pain post-surgery. Addressing these issues requires ongoing research into more advanced surgical techniques, materials, and post-operative care protocols aimed at reducing these risks and enhancing patient recovery. Innovations in mesh materials and techniques, such as the development of bio-absorbable meshes and robot-assisted surgeries, promise to improve outcomes and reduce complications, thus driving further adoption of hernia repair procedures worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.56 billion |
Estimated Year [2024] | USD 4.78 billion |
Forecast Year [2030] | USD 6.52 billion |
CAGR (%) | 5.23% |
Regional Insights
In the Americas, especially the United States, there is a high demand for technologically advanced hernia repair products such as composite meshes and biologic allografts, driven by a strong healthcare infrastructure and substantial investment in R&D. Major companies in this region benefit from robust distribution networks and comprehensive product portfolios. The APAC region is witnessing rapid growth in hernia repair, fueled by increasing awareness about advanced hernia repair options, rising healthcare expenditure, and improving healthcare facilities. However, the market here is more fragmented, with both global players and local companies, leading to a diverse product range and competitive pricing strategies. The EMEA region presents a diverse scenario with advanced markets in Western Europe focusing on innovation and quality, while markets in the Middle East and Africa are more price-sensitive and gradually adopting newer technologies. Regional companies are expanding in the EMEA region, offering a mix of advanced and cost-effective solutions to cater to varied market demands.
Market Insights
The market dynamics represent an ever-changing landscape of the Hernia Repair Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hernia Repair Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hernia Repair Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for USD 540 Million
STERIS PLC entered into a definitive agreement to acquire surgical and laparoscopic instrumentation and sterilization container assets from Becton, Dickinson, and Company (BD) for a total consideration of USD 540 million. This strategic acquisition encompasses the well-regarded V. Mueller, Snowden-Pencer, and Genesis brands, reinforcing STERIS's position in providing premium surgical instruments and sterilization solutions to healthcare customers. [Published On: 2023-06-20]
US Regulatory Approval Granted for LiquiBandFix8A
Advanced Medical Solutions Group PLC, a significant player in tissue-healing technologies, announces its recent accomplishment of receiving Pre-Market Approval (PMA) from the U.S. Food and Drug Administration (FDA) for LiquiBandFix8. This approval, a pivotal moment for the company, came ahead of the anticipated schedule, just seven months post-submission, signifying a major success for our debut PMA application. This rapid authorization speaks to our application's exceptional quality and highlights the significant advantages LiquiBandFix8 offers patients undergoing hernia surgeries. [Published On: 2023-06-05]
Tissium Raises Euro 50 Million (USD 54 Million) in Series D Funding to Finance its Commercial Launch and Platform Extension
Tissium, an innovative player in biomorphic programmable polymers for tissue reconstruction, secured a euro 50 million (USD 50 million) investment in its Series D financing round. This fundraising achievement aligns with a series of pivotal accomplishments for the company, particularly the progression of its study of COAPTIUM Connect for nerve repair in Australia, alongside various regulatory endeavors. The newly secured funds are instrumental in advancing TISSIUM's strategic milestones, explicitly supporting the commercial launch of its inaugural products in nerve and hernia repair. [Published On: 2023-05-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hernia Repair Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Hernia Repair Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Medical Solutions Limited, Aran Biomedical, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company,, BioCer Entwicklungs-GmbH, Dolphin Sutures, DynaMesh, Herniamesh Srl, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lotus Surgicals Pvt. Ltd., Medtronic PLC, Olimp - Surgical sutures, Orion Sutures India Pvt. Ltd., SERAG-WIESSNER GmbH & Co. KG, Shandong Haidike Medical Products Co., Ltd., Spire Healthcare Group PLC, SUGII SURGICAL INDIA PRIVATE LIMITED, Surgical Sutures Private Limited, TELA Bio, Inc, Unisur Lifecare Private Limited, W. L. Gore & Associates, Inc., and Zhejiang Geyi Medical Instrument Co., Ltd..
Market Segmentation & Coverage